Core Viewpoint - The article discusses the ongoing investor compensation case against Nongshang Environment (300536) due to false statements, highlighting that affected investors still have opportunities for claims following a warning from the Hubei Securities Regulatory Bureau regarding the company's financial disclosures [1][2][3]. Group 1: Company Violations - Nongshang Environment received a warning from the Hubei Securities Regulatory Bureau for failing to disclose its 2023 annual performance forecast within the required timeframe and not alerting investors about the risk of delisting [1][2]. - The company's 2023 annual report revealed a revenue of 71.43 million yuan and a net loss attributable to shareholders of 29.77 million yuan, leading to a delisting risk warning effective April 30, 2024 [1][2]. Group 2: Investor Compensation Opportunities - Investors who purchased Nongshang Environment shares between February 1, 2024, and April 29, 2024, and sold or continued to hold the shares after April 29, 2024, are eligible to initiate compensation claims [2][3]. - The law firm representing investors has a history of successfully handling nearly 200 cases and has ongoing claims for around 300 stocks, with some already resulting in victories or settlements [2][3].

Core Viewpoint - The article discusses the ongoing investor compensation case against Guandian Defense (688287) due to false statements made by the company, highlighting the potential for affected investors to seek compensation through legal channels [1][5]. Group 1: Legal Proceedings - The investor compensation case has been officially filed with the Shanghai Financial Court, and further arrangements are awaited [5]. - The law firm is continuing to accept compensation claims from other investors affected by the company's actions [5]. Group 2: Regulatory Violations - Guandian Defense failed to disclose non-operating fund occupation related party transactions and external guarantee matters from 2022 to 2023, leading to significant omissions in their reports [5]. - The company did not disclose 12, 16, 13, and 16 external guarantee matters in its semi-annual and annual reports for 2022 and 2023, with guarantee amounts of 25.992 million, 32.292 million, 17.500 million, and 20.500 million respectively, representing 23.36%, 32.32%, 16.49%, and 20.38% of the company's net assets during those periods [2][5]. Group 3: Financial Misstatements - In the 2022 annual report, Guandian Defense falsely recorded a total of 139 million yuan transferred to five companies, which inflated the bank deposits reported by 139 million yuan, accounting for 13.37% of the total assets disclosed [4][7]. - The actions of the company are in violation of the Securities Law, constituting illegal behavior as defined by the law [4][7].

Core Viewpoint - Hubei Jiuyou Investment Co., Ltd. (Jiuyou Co., ST Jiuyou) has been penalized by the China Securities Regulatory Commission (CSRC) for failing to disclose related party transactions and for falsifying financial reports from 2020 to 2023, leading to significant financial misstatements and potential investor compensation claims [2][4][12]. Group 1: Violations and Financial Misstatements - Jiuyou Co. failed to disclose a related party transaction involving the acquisition of 90% equity in Bozhou Zongxiang Information Technology Co., Ltd. for approximately 63.97 million yuan, which constituted 142.30% of its net assets at the time [2][8]. - The 2020 annual report was found to have inflated non-operating income by 63.97 million yuan, which increased the total profit by 471.03% [3][9]. - From 2021 to 2023, Jiuyou Co. subsidiaries inflated revenues and profits through fictitious business activities, with the 2021 report overstating revenue by 43.71 million yuan (16.29% of total revenue), the 2022 report by 151.42 million yuan (49.44%), and the 2023 report by 164.22 million yuan (40.64%) [10][11]. Group 2: Regulatory Actions and Consequences - The CSRC has ordered Jiuyou Co. and its actual controller, Li Ming, to rectify the violations, issue warnings, and impose fines [4][11]. - Jiuyou Co. acknowledged accounting errors that could lead to a reduction in non-operating income and net profit for 2020, affecting subsequent financial reports [4][11]. - Legal actions are being initiated for investor compensation due to the violations, with specific conditions for eligibility outlined for affected investors [12][13].

Core Viewpoint - ST Huizhou (stock code: 002122) has been penalized by the Zhejiang Securities Regulatory Bureau for violations related to information disclosure, resulting in a fine and warnings for the company and its responsible personnel [1][5]. Group 1: Administrative Penalties - ST Huizhou received a warning and a fine of 5 million yuan for information disclosure violations [1][5]. - The main responsible persons, Jiang Xueqian and Wu Jianfei, were each fined 2.5 million yuan and received warnings [1][5]. - Other responsible personnel, Chen Yingying and Wu Ning, were fined 1.5 million yuan each and also received warnings [1][5]. Group 2: Investor Compensation - Investors who suffered losses due to ST Huizhou's violations can initiate lawsuits for compensation, as the administrative penalty provides the legal basis for such actions [2][6]. - The preliminary conditions for compensation include purchasing ST Huizhou stock between April 29, 2020, and April 25, 2025, and holding the stock until the closing on April 25, 2025 [2][6]. - Required materials for the lawsuit include original stock transaction statements, a copy of the investor's ID, and a confirmation of the securities account information from the brokerage [3][8].

Core Viewpoint - Hunan Kexin Information Technology Co., Ltd. (stock code: 300730) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into suspected violations of information disclosure laws, which may lead to investor compensation claims [1][6]. Group 1: Investigation Details - The company received the CSRC's "Notice of Investigation" on November 17, 2025, due to allegations of information disclosure violations [6]. - The investigation is based on the "Securities Law of the People's Republic of China" and the "Administrative Penalty Law of the People's Republic of China" [6]. Group 2: Investor Compensation - Investors who purchased Kexin Information shares between its listing and November 18, 2025, and still held the shares at the close of trading on that date, may be eligible for compensation [2][7]. - The initial conditions for compensation include holding the stock and having a trading record that shows all transactions from the first purchase to the date of the claim [7]. Group 3: Required Documentation for Claims - Investors must prepare the following documents for compensation claims: 1. Original stock trading statement stamped by the brokerage, showing all transactions [7]. 2. A photocopy of the investor's ID card [8]. 3. A securities account confirmation slip issued by the brokerage [9]. Group 4: Legal Commentary - Lawyer Niu Bin from Shanghai Baiyue Law Firm stated that investors have the right to claim compensation for losses caused by the company's violations of information disclosure laws [6][10].

Core Viewpoint - The announcement from Renfu Pharmaceutical Group Co., Ltd. regarding the receipt of an administrative penalty notice from the Hubei Securities Regulatory Bureau indicates that investors affected by information disclosure violations may have grounds for compensation claims [1][6]. Summary by Sections Administrative Penalty Notice - On December 12, 2024, Renfu Pharmaceutical (stock code: 600079) announced it received an administrative penalty notice from the Hubei Securities Regulatory Bureau [1][6]. Compensation Conditions - Investors who purchased ST Renfu shares between April 23, 2023, and October 24, 2024, and still held the shares at the close on October 24, 2024, may preliminarily qualify for compensation [2][8]. - The final scope of compensation will be determined by court rulings [2]. Required Documentation for Claims - Investors must prepare the following documents to support their claims: 1. Original stock transaction statement stamped by the brokerage, showing all trading records from the first purchase to the date of printing, including remaining shares for current holders [2][8]. 2. A photocopy of the investor's ID card, showing both sides [3]. 3. A securities account confirmation slip issued by the brokerage, detailing account information [4][9]. Legal Commentary - Lawyer Niu Bin from Shanghai Baiyue Law Firm stated that the conditions for compensation registration are based on the administrative penalty notice and do not constitute investment advice or guarantees regarding the outcome of claims [5][10].

Group 1 - The core issue involves investor claims against Ba Yi Steel (600581) due to alleged violations of information disclosure laws, with a court case initiated on December 16, 2025 [1][7] - Investors who purchased Ba Yi Steel shares before November 8, 2025, and sold or held them afterward are eligible to file claims [2][7] - The law firm representing the investors is also accepting claims from other investors affected by the situation [1][2] Group 2 - Yi Shi Te (300376) has been found guilty of inflating revenue and profits through false trade practices and financing-related activities, as confirmed by the China Securities Regulatory Commission (CSRC) on December 31, 2024 [3][4][5] - The fraudulent activities included false trade operations, financing procurement, and data center integration services, leading to misstatements in annual reports from 2017 to 2021 [5][8] - Investors who bought Yi Shi Te shares between March 15, 2018, and May 12, 2023, and sold or held them afterward can also initiate claims [6][9]

Core Viewpoint - Ningke Biological (600165) is facing legal actions due to false statements in its financial reports, leading to investor claims for compensation following a court ruling in favor of investors [1][5]. Group 1: Legal Proceedings - The law firm Shanghai Jiucheng has submitted another case for investor compensation against Ningke Biological on December 16, 2025 [1][11]. - Investors represented by the law firm have won a previous court ruling, and the team is continuing to accept new claims from other investors [5][11]. Group 2: Regulatory Violations - On April 4, 2024, Ningke Biological announced that it received an administrative penalty from the Ningxia Regulatory Bureau of the CSRC, confirming violations including false records in its 2022 annual report [7][11]. - The company inflated its 2022 revenue by 76.5941 million yuan and its total profit by 77.222 million yuan, which accounted for 11.25% and 46.59% of the respective totals [7][11]. Group 3: Disclosure Failures - Ningke Biological failed to timely disclose significant events, including major debts, frozen bank accounts, and the suspension of key subsidiary operations [8][10][12]. Group 4: Investor Compensation Eligibility - Investors who purchased Ningke Biological shares between November 22, 2022, and April 6, 2023, or between April 28, 2024, and October 31, 2024, may still initiate claims for compensation [10][14].

3． 证券账户查询确认单：由证券公司营业部出具的载明账户信息的查询单。 牛彬律师声明（牛彬律师专栏） 2024年11月21日晚间，广东聚石化学（维权）股份有限公司（证券简称：聚石化学，证券代码： 688669）发布《关于收到中国证券监督管理委员会立案告知书的公告》。公告显示，公司于近日收到中 国证监会下发的《立案告知书》。因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中 华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。 上海百悦律师事务所牛彬律师表示，聚石化学因涉嫌信息披露违法违规被证监会立案，投资者或可依法 索赔。暂定索赔条件为：在2024年11月21日之前买入聚石化学（688669）股票，且在2024年11月22日之 后卖出或继续持有的亏损投资者。（最终索赔范围以法院判决认定为准）（聚石化学维权入口） 索赔材料准备： 1． 股票交易对账单原件（需加盖证券公司营业部业务印章）：需包含从首次买入聚石化学股票之日起 至打印之日的所有交易记录。仍持有该股票的投资者，对账单应显示剩余持股数量。 登录新浪财经APP 搜索【信披】查看更多考评等级 2． 身份证复印件：投资者本人的身份证正反面复 ...

日前已经收到传票，2025年12月23日，上海久诚律师事务所股民索赔律师许峰代理的英飞拓（002528） 投资者索赔将在深圳中院开庭审理。需要特别提示的是，该案前期已有投资者胜诉先例。（许峰律师专 栏） 许峰律师代理的英飞拓投资者索赔案此前已获得法院立案，律师团队同步还在继续推进后续案件的立案 工作，还在继续接受其他投资者的索赔委托。 2025年1月24日晚，英飞拓公告收到证监会下发的《立案告知书》，因涉嫌信息披露违法违规，根据 《证券法》《行政处罚法》等法律法规，证监会决定对公司立案。 专门从事股票索赔法律事务的上海久诚律师事务所主任许峰律师认为，根据前期投资者胜诉判决，在 2020年4月30日到2024年4月30日之间买入英飞拓股票，并且在2024年4月30日后卖出或继续持有股票的 投资者，目前还可发起索赔。（ST英飞拓维权入口） 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 登录新浪财经 ...